NCT05882201

Brief Summary

Pediatric orthopedic surgical procedures require a multimodal approach for anesthetic management that maximizes both patient comfort and safety. (1) A multimodal strategy for perioperative pain management is often required for children undergoing orthopedic surgery including pharmacological methods, and regional anesthesia (R.A). (1,2) Recent guidelines published jointly by the European Society of Regional Anesthesia (ESRA) and the American Society of Regional Anesthesia (ASRA) recommend that regional blocks can and should preferably be performed under general anesthesia or deep sedation in children of all ages. (3,4) Many studies investigated the safety of regional pediatric nerve blocks These studies showed pediatric complication rates consistent with adult data. These complications include nerve injury, intravascular injection and local anesthetics systemic toxicity (LAST), and acute compartmental syndrome. these complications have been minimized by ultrasound-guided nerve block in pediatrics. (5) The annual incidence of pediatric femoral fractures is estimated to be 19 per 100,000. Femoral fractures are usually associated with other injuries such as intracranial hemorrhages, lung contusions, hemothorax or pneumothorax, and other organ injuries which make regional anesthesia (R.A) is preferable as a sole technique or combined with general anesthesia to decrease the overall dosage of anesthetics and opioids. (6) The most tangible advantage of RA is profound and prolonged pain relief. Alternatively, pain relief can be given by opioids which are known to cause nausea, vomiting, respiratory depression, decrease in gut motility and increase apneic spells in the population vulnerable to the same. Nonsteroidal anti- inflammatory drugs can affect the immature renal system adversely. RA offers pain relief without changing the physiological milieu. (7) Fascia iliaca Compartment Block (FICB) has been widely used for postoperative analgesia in patients undergoing hip, femoral bone, and knee surgical procedures. FICB was first introduced by Dalens et al in 1989. This regional plane block technique was used to block the femoral nerve and the lateral femoral cutaneous nerve of the thigh and the obturator nerve with a high level of safety and success, well-suited for the anterolateral surgeries of the thigh. (8,9) Femoral nerve block (FNB) has been widely used for postoperative analgesia in patients undergoing hip, and femoral bone surgical procedures, it provides anesthesia and analgesia for the lateral aspect of the thigh and the femur bone. (10,11) FICB has a wider range of anesthesia and analgesia in lower limbs compared to FNB. but the use of dilute injectate in FICB may minimize sensory and motor block than FNB. (1,16) This study will be conducted to evaluate the effects of FICB vs FNB in pain control in pediatrics undergoing femoral fracture repair surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 31, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

May 31, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

April 4, 2023

Last Update Submit

May 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain

    Assessing the Postoperative pain using The Face, Legs, Activity, Cry and Consolability (FLACC) scale.

    expected within 6 months

Secondary Outcomes (1)

  • Postoperative need for analgesia

    expected within 6 months

Study Arms (3)

Control group

PLACEBO COMPARATOR

Control group

Procedure: General care

Group FICB

EXPERIMENTAL

✓ Group FICB; (30 patients) Fascia Iliaca compartment block group.

Procedure: Fascia Iliaca compartment block group

Group FNB

EXPERIMENTAL

✓ Group FNB; (30 patients) Femoral nerve block group.

Procedure: Femoral nerve block group

Interventions

Group FICB Fascia: with the patient supine, the skin was prepped and draped with alcohol solution 70%, . A 22-G needle will be visualized entering the fascia Lata and the FI. bupivacaine, up to 2.5mg/kg of lean body weight with a volume of injectate of .5 ml/kg up to 40 ml will be injected after aspiration beneath the fascia Lata.

Group FICB

✓ Group FNB; With the patient supine, the skin will be prepped and draped with alcohol solution 70% The nerve in the crosssection is a triangular white structure lateral to the femoral artery. Ultrasoundallows direct visualization of the needle and nerve as well as real-time monitoring of the injection of local anesthetic. An in-plane approach will be used to direct needle placement to the femoral nerve and inject after aspiration with bupivacaine, up to 2.5mg/kg of lean body weight with a volume of injectate of .5 ml/kg up to 40ml.

Group FNB
General carePROCEDURE

using ordinary technique

Control group

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All patients are within the age range of 5 to 12 years old.
  • Isolated Traumatic fracture of the femur bone.
  • ASA I or II physical status.
  • Pts weighed ≥10 kg

You may not qualify if:

  • Refusal of the patient's parents or legal guardians to give informed consent.
  • History of allergy to any of the study drugs.
  • Injury at the site of injection.
  • Vascular compromise an injured leg.
  • Bilateral femur fracture.
  • Recent trauma to the head, chest, or abdomen.
  • history of bleeding disorder, or anticoagulant therapy.
  • Preoperative intake of opioid or non-steroidal anti-inflammatory drugs within 24 h before surgery.
  • Neurological and/or psychological diseases.
  • Associated cardio-respiratory illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Menoufia university hospitails

Shibīn al Kawm, Menoufya, 32111, Egypt

RECRUITING

Related Publications (1)

  • Wu JP. Pediatric Anesthesia Concerns and Management for Orthopedic Procedures. Pediatr Clin North Am. 2020 Feb;67(1):71-84. doi: 10.1016/j.pcl.2019.09.006.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: * The study will be a prospective randomized controlled study. Patients will be randomized by a computer-generated program into 3 equal parallel groups that will be randomly assigned to either: * Control group;(30 patient). * Group FICB; (30 patients) Fascia Iliaca compartment block group. * Group FNB; (30 patients) Femoral nerve block group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

April 4, 2023

First Posted

May 31, 2023

Study Start

June 1, 2023

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

May 31, 2023

Record last verified: 2023-05

Locations